STOCK TITAN

[SCHEDULE 13G/A] Biohaven Ltd. Amended Passive Investment Disclosure

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Janus Henderson Group plc filed an amended Schedule 13G reporting beneficial ownership of 16,803,459 common shares of Biohaven Ltd., representing 12.7% of the class as of the triggering event on 01/30/2026.

The shares are held across multiple investment advisers and their client accounts, referred to as Managed Portfolios. Janus Henderson’s asset managers share voting and investment power over these Biohaven shares, while the Managed Portfolios themselves receive all dividends and sale proceeds. The filing states the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Biohaven.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



JANUS HENDERSON GROUP PLC
Signature:Kristin Mariani
Name/Title:Head of North America Compliance
Date:02/06/2026
Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7

Biohaven

NYSE:BHVN

BHVN Rankings

BHVN Latest News

BHVN Latest SEC Filings

BHVN Stock Data

1.43B
120.40M
11.55%
82.71%
10.06%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN